These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19921425)

  • 1. A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk.
    Yang R; Schlehe B; Hemminki K; Sutter C; Bugert P; Wappenschmidt B; Volkmann J; Varon R; Weber BH; Niederacher D; Arnold N; Meindl A; Bartram CR; Schmutzler RK; Burwinkel B
    Breast Cancer Res Treat; 2010 Jun; 121(3):693-702. PubMed ID: 19921425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women.
    Tchatchou S; Jung A; Hemminki K; Sutter C; Wappenschmidt B; Bugert P; Weber BH; Niederacher D; Arnold N; Varon-Mateeva R; Ditsch N; Meindl A; Schmutzler RK; Bartram CR; Burwinkel B
    Carcinogenesis; 2009 Jan; 30(1):59-64. PubMed ID: 19028706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis.
    Gao LB; Bai P; Pan XM; Jia J; Li LJ; Liang WB; Tang M; Zhang LS; Wei YG; Zhang L
    Breast Cancer Res Treat; 2011 Jan; 125(2):571-4. PubMed ID: 20640596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variants within miR-126 and miR-335 are not associated with breast cancer risk.
    Yang R; Dick M; Marme F; Schneeweiss A; Langheinz A; Hemminki K; Sutter C; Bugert P; Wappenschmidt B; Varon R; Schott S; Weber BH; Niederacher D; Arnold N; Meindl A; Bartram CR; Schmutzler RK; Müller H; Arndt V; Brenner H; Sohn C; Burwinkel B
    Breast Cancer Res Treat; 2011 Jun; 127(2):549-54. PubMed ID: 21046227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of single nucleotide polymorphisms in Pre-miR-27a, Pre-miR-196a2, Pre-miR-423, miR-608 and Pre-miR-618 with breast cancer susceptibility in a South American population.
    Morales S; Gulppi F; Gonzalez-Hormazabal P; Fernandez-Ramires R; Bravo T; Reyes JM; Gomez F; Waugh E; Jara L
    BMC Genet; 2016 Jul; 17(1):109. PubMed ID: 27421647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SNPs in ultraconserved elements and familial breast cancer risk.
    Yang R; Frank B; Hemminki K; Bartram CR; Wappenschmidt B; Sutter C; Kiechle M; Bugert P; Schmutzler RK; Arnold N; Weber BH; Niederacher D; Meindl A; Burwinkel B
    Carcinogenesis; 2008 Feb; 29(2):351-5. PubMed ID: 18174240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis.
    Shen J; Ambrosone CB; DiCioccio RA; Odunsi K; Lele SB; Zhao H
    Carcinogenesis; 2008 Oct; 29(10):1963-6. PubMed ID: 18660546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between hsa-mir-146a genotype and tumor age-of-onset in BRCA1/BRCA2-negative familial breast and ovarian cancer patients.
    Pastrello C; Polesel J; Della Puppa L; Viel A; Maestro R
    Carcinogenesis; 2010 Dec; 31(12):2124-6. PubMed ID: 20810544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A genetic variant located in miR-423 is associated with reduced breast cancer risk.
    Smith RA; Jedlinski DJ; Gabrovska PN; Weinstein SR; Haupt L; Griffiths LR
    Cancer Genomics Proteomics; 2012; 9(3):115-8. PubMed ID: 22593246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of polymorphisms and haplotypes in the human growth hormone 1 (GH1) gene with breast cancer.
    Wagner K; Hemminki K; Israelsson E; Grzybowska E; Klaes R; Chen B; Butkiewicz D; Pamula J; Pekala W; Försti A
    Endocr Relat Cancer; 2005 Dec; 12(4):917-28. PubMed ID: 16322331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer.
    Landi D; Gemignani F; Naccarati A; Pardini B; Vodicka P; Vodickova L; Novotny J; Försti A; Hemminki K; Canzian F; Landi S
    Carcinogenesis; 2008 Mar; 29(3):579-84. PubMed ID: 18192692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker.
    Brendle A; Lei H; Brandt A; Johansson R; Enquist K; Henriksson R; Hemminki K; Lenner P; Försti A
    Carcinogenesis; 2008 Jul; 29(7):1394-9. PubMed ID: 18550570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A variant affecting miRNAs binding in the circadian gene Neuronal PAS domain protein 2 (NPAS2) is not associated with breast cancer risk.
    Wang F; Hu Z; Yang R; Tang J; Liu Y; Hemminki K; Sutter C; Wappenschmidt B; Niederacher D; Arnold N; Meindl A; Bartram CR; Schmutzler RK; Burwinkel B; Shen H
    Breast Cancer Res Treat; 2011 Jun; 127(3):769-75. PubMed ID: 21140207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common genetic variants in pre-microRNAs and risk of gallbladder cancer in North Indian population.
    Srivastava K; Srivastava A; Mittal B
    J Hum Genet; 2010 Aug; 55(8):495-9. PubMed ID: 20520619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer.
    Yang H; Dinney CP; Ye Y; Zhu Y; Grossman HB; Wu X
    Cancer Res; 2008 Apr; 68(7):2530-7. PubMed ID: 18381463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common genetic polymorphisms in pre-microRNAs were associated with increased risk of dilated cardiomyopathy.
    Zhou B; Rao L; Peng Y; Wang Y; Chen Y; Song Y; Zhang L
    Clin Chim Acta; 2010 Sep; 411(17-18):1287-90. PubMed ID: 20488170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rare ERBB2 variant Ile654Val is associated with an increased familial breast cancer risk.
    Frank B; Hemminki K; Wirtenberger M; Bermejo JL; Bugert P; Klaes R; Schmutzler RK; Wappenschmidt B; Bartram CR; Burwinkel B
    Carcinogenesis; 2005 Mar; 26(3):643-7. PubMed ID: 15550452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variations in miR-27a gene decrease mature miR-27a level and reduce gastric cancer susceptibility.
    Yang Q; Jie Z; Ye S; Li Z; Han Z; Wu J; Yang C; Jiang Y
    Oncogene; 2014 Jan; 33(2):193-202. PubMed ID: 23246964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive assessment of the association between miRNA polymorphisms and gastric cancer risk.
    Xu Q; Liu JW; Yuan Y
    Mutat Res Rev Mutat Res; 2015; 763():148-60. PubMed ID: 25795117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of correlation between genetic variants in three microRNA genes (hsa-miR-146a, hsa-miR-502 binding site, hsa-miR-27a) and breast cancer risk.
    Parchami Barjui S; Reiisi S; Ebrahimi SO; Shekari B
    Curr Res Transl Med; 2017 Nov; 65(4):141-147. PubMed ID: 29128203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.